References
- Breathnach SM. Drug reactions. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s textbook of dermatology, 8th ed. Oxford: Wiley-Blackwell; 2010:130–131
- Cheng KK-F. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. Eur J Cancer Care 2008;17:306–311
- Woo SK. Chemotherapy-associated ulcerative mucositis. In: Goldsmith LA, Katz SI Gilchrest BA, et al. eds. Fitzpatrick’s dermatology in general medicine. 8th ed. USA: McGraw-Hill; 2012:832
- Pico JL, Avila-Garavito A, Naccache P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 1998;3:446–451
- Raber-Durlacher JE, Weijl NI, Abu Saris M, et al. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 2000;8:366–371
- Frampton JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994;48:731–760
- Crawford J, Tomita DK, Mazanet R, et al. Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. Cytokines Cell Mol Ther 1999;5:187–193
- Lyman GH, Kuderer NM. Filgrastim in patients with neutropenia: potential effects on quality of life. Drugs 2002;62:65–78
- Hoffbrand V, Moss P. Haemapoiesis. Essential haematology. 6th ed. West Sussex: Wiley-Blackwell; 2011:1–15
- Lieschke GJ, Ramenghi U, O’Connor MP, et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 1992;82:589–595
- Mazokopakis EE, Vrentzos GE, Papadakis JA, et al. Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexate-induced oral mucositis. Phytomedicine 2005;12:25–27
- Maiguma T, Hayashi Y, Ueshima S, et al. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. Int J Clin Pharmacol Ther 2008;46:584–590
- Abbass K, Haveman L, Gertner E. Esophagitis dissecans superficialis due to severe methotrexate toxicity. Endoscopy 2014;46:E99–E100
- Maroñas-Jiménez L, Castellanos-González M, Sanz Bueno J, Vanaclocha Sebastián F. Acral erosions and ulcers: an early sign of severe acute methotrexate toxicity. Actas Dermosifiliogr 2014;105:322–323
- Jindal N, Arora K, Jindal P, et al. Inflamed psoriatic plaques: drug toxicity or disease exacerbation?. Indian J Pharmacol 2013;45:410–411
- van Hasselt JG, van Eijkelenburg NK, Huitema AD, et al. Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate. Antimicrob Agents Chemother 2013;57:2878–2881
- Schmidt E, Thoennissen NH, Rudat A, et al. Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Ann Oncol 2008;19:1644–1649